Literature DB >> 10821490

Increased angiogenesis in papillary thyroid carcinoma but lack of prognostic importance.

L A Akslen1, V A Livolsi.   

Abstract

Angiogenesis is important for tumor growth and progress, and the intratumor density of microvessels is a significant prognostic factor in many tumor types. The role in thyroid cancer has not been well studied, and we therefore examined a series of 128 papillary carcinomas with respect to microvessel density (MVD) and patient survival. Follow-up was obtained for all cases (median, 145 months). We found a mean MVD of 216 per mm2 (range, 35-751), and there was an average of 3.14 times more vessels in the tumors, when compared with surrounding non-neoplastic thyroid tissue. MVD was inversely related to age, tumor diameter, histological grade, and primary tumor extent. Furthermore, increasing MVD tended to be associated with improved survival (P = .056). In conclusion, our data indicate that angiogenesis is important for the development and maintenance of papillary thyroid carcinomas, although it was not identified as a prognostic factor.

Entities:  

Mesh:

Year:  2000        PMID: 10821490     DOI: 10.1053/1-ip.2000.6548

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  11 in total

1.  Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma.

Authors:  İlknur Bingül; Pervin Vural; Semra Doğru-Abbasoğlu; Esra Çil; Müjdat Uysal
Journal:  J Clin Lab Anal       Date:  2016-12-07       Impact factor: 2.352

2.  Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma.

Authors:  C Eloy; J Santos; P Soares; M Sobrinho-Simões
Journal:  Virchows Arch       Date:  2011-11-12       Impact factor: 4.064

3.  Thyroid cancer: emerging role for targeted therapies.

Authors:  Jennifer A Sipos; Manisha H Shah
Journal:  Ther Adv Med Oncol       Date:  2010-01       Impact factor: 8.168

4.  The vascular landscape of human cancer.

Authors:  Benjamin M Kahn; Alfredo Lucas; Rohan G Alur; Maximillian D Wengyn; Gregory W Schwartz; Jinyang Li; Kathryn Sun; H Carlo Maurer; Kenneth P Olive; Robert B Faryabi; Ben Z Stanger
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

5.  Vascular endothelial growth factor (VEGF), VEGF receptors expression and microvascular density in benign and malignant thyroid diseases.

Authors:  Ala'eddin Jebreel; James England; Karen Bedford; Justin Murphy; Laszlo Karsai; Stephen Atkin
Journal:  Int J Exp Pathol       Date:  2007-08       Impact factor: 1.925

Review 6.  The pituitary tumor transforming gene in thyroid cancer.

Authors:  G D Lewy; N Sharma; R I Seed; V E Smith; K Boelaert; C J McCabe
Journal:  J Endocrinol Invest       Date:  2012-04-05       Impact factor: 4.256

7.  Relationships between Lymph Node Metastasis and Expression of CD31, D2-40, and Vascular Endothelial Growth Factors A and C in Papillary Thyroid Cancer.

Authors:  Sang-Hyuk Lee; Sung-Jin Lee; Sung-Min Jin; No-Hee Lee; Dong-Hoon Kim; Seung-Wan Chae; Jin-Hee Sohn; Won-Serk Kim
Journal:  Clin Exp Otorhinolaryngol       Date:  2012-08-27       Impact factor: 3.372

8.  VEGF expression, microvessel density and dendritic cell decrease in thyroid cancer.

Authors:  Maya Gulubova; Koni Ivanova; Julian Ananiev; Julieta Gerenova; Aleksandar Zdraveski; Hristo Stoyanov; Tatyana Vlaykova
Journal:  Biotechnol Biotechnol Equip       Date:  2014-09-25       Impact factor: 1.632

Review 9.  Angiogenesis in Malignant Thyroid Tumors.

Authors:  Matvey Vladimir Sprindzuk
Journal:  World J Oncol       Date:  2011-01-01

10.  Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis.

Authors:  C Li; R Gardy; B K Seon; S E Duff; S Abdalla; A Renehan; S T O'Dwyer; N Haboubi; S Kumar
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.